RE:short reportTerrific response. Thanks. This is the second ridiculous short report I've encountered in my portfolio in the past month. The other being EXRO. Here's hoping the WELL response is as excellent as the takedown response by the management of EXRO. It's imperative regulators get a handle on this nonsense. These are both excellent small caps that shouldn't have unfair obstacles placed in their path in the form of what is essentially false research.